市场调查报告书
商品编码
1410805
女性绝育设备的全球市场 - 市场规模(按细分市场)、份额、监管、报销、程序、预测(~2033 年)Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
随着大多数国家教育程度和收入的提高,女性绝育装置的使用可能会保持稳定(下降/增加率非常低)。
可逆法和男性绝育越来越受欢迎。 输卵管切割被认为比女性绝育更安全,因为失败不会增加子宫外孕的风险。 然而,降低性传染病风险、无副作用或低副作用的新型低成本技术/设备的引入将显着抑制输卵管夹/环市场,并在未来创造新的机会,这是有可能的。
本报告研究和分析了全球女性绝育设备市场,并提供了有关每个细分市场的市场规模、市场趋势、竞争格局以及 COVID-19 影响的资讯。
市场模型的主要内容如下。
已上市的女性绝育设备和不断变化的竞争格局
全球、区域和国家层面的特定市场考量
透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息,使您能够更深入地研究市场动态。
目标公司
Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Reproductive Health Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Female Sterilization Devices market for the year 2020 and beyond. Female sterilization is a permanent procedure where the fallopian tubes are blocked using surgical and non-surgical techniques. Use of female sterilization devices may remain stable (with very low rates of decline/increase) in future with greater educational attainment and income in most of the countries.
Reversible methods and male sterilization are increasing in popularity; vasectomy is considered to be safer than female sterilization as there is no increased risk of ectopic pregnancy if vasectomy fails. However, introduction of new and low cost technologies/devices that reduce the risk of STD's, and cause no/less side effects may hinder the tubal clips/rings market to a large extent and may generate new opportunities in the future.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Female Sterilization Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Utah Medical Products Inc, Olympus Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable